Increased risk of suicide in New South Wales men with prostate cancer: analysis of linked population-wide data

- Smith, David P., Calopedos, Ross, Bang, Albert, Yu, Xue Qin, Egger, Sam, Chambers, Suzanne, O'Connell, Dianne L.

Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines

- Brzozowski, Joshua S., Jankowski, Helen, Bond, Danielle R., McCague, Siobhan B., Munro, Benjamin R., Predebon, Melanie J., Scarlett, Christopher J., Skelding, Kathryn A., Weidenhofer, Judith

Long-term psychological and quality-of-life effects of active surveillance and watchful waiting after diagnosis of low-risk localised prostate cancer

- Egger, Sam J., Calopedos, Ross J., O'Connell, Dianne L., Chambers, Suzanne K., Woo, Henry H., Smith, David P.

miR-518f-5p decreases tetraspanin CD9 protein levels and differentially affects non-tumourigenic prostate and prostate cancer cell migration and adhesion

- Bond, Danielle R., Naudin, Crystal, Carroll, Adam P., Goldie, Belinda J., Brzozowski, Joshua S., Jankowski, Helen M., Cairns, Murray J., Ashman, Leonie K., Scarlett, Christopher J., Weidenhofer, Judith

Moderate hypofractionation for prostate cancer: A user's guide

- Pryor, David I., Turner, Sandra L., Tai, Keen Hun, Tang, Colin, Sasso, Giuseppe, Dreosti, Marcus, Woo, Henry H., Wilton, Lee, Martin, Jarad M.

Moderately hypofractionated prostate external-beam radiotherapy: an emerging standard

- Martin, Jarad M., Supiot, Stephane, Keall, Paul J., Catton, Charles N.

Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer

- Taaffe, Dennis R., Buffart, Laurien M., Newton, Robert U., Spry, Nigel, Denham, James, Joseph, David, Lamb, David, Chambers, Suzanne K., Galvão, Daniel A.

Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: evaluating deformably registered dose distribution addition using parameter-based addition

- Moulton, Calyn R., House, Michael J., Lye, Victoria, Tang, Colin I., Krawiec, Michele, Joseph, David J., Denham, James W., Ebert, Martin A.

Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR)

- Nair-Shalliker, Visalini, Yap, Sarsha, Nunez, Carlos, Egger, Sam, Rodger, Jennifer, Patel, Manish I., O'Connell, Dianne L., Sitas, Freddy, Armstrong, Bruce K., Smith, David P.

Cancer-related hospitalisations and "unknown' stage prostate cancer: a population-based record linkage study

- Luo, Qingwei, Yu, Xue Qin, Smith, David Paul, Goldsbury, David Eamon, Cooke-Yarborough, Claire, Patel, Manish Indravadan, O'Connell, Dianne Lesley

Decision-making in prostate cancer – choosing active surveillance over other treatment options: a literature review

- Bayliss, David R., Duff, Jed, Stricker, Philip, Walker, Kim

Hypofractionated prostate treatments: dose, motion monitoring and credentialling

- Legge, Kimberley

Management and outcomes of Gleason six prostate cancer detected on needle biopsy: a single-surgeon experience over 6 years

- March, Brayden, Koufogiannis, George, Louie-Johnsun, Mark

Measuring personal and functional changes in prostate cancer survivors: development and validation of the FADE: data from the TROG 03.04 RADAR trial

- Bitsika, Vicki, Sharpley, Christopher F., Christie, David R. H., Bradford, Rosemary, Steigler, Allison, Denham, James W.

New challenges in psycho-oncology research III: a systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications

- Chambers, Suzanne K., Hyde, Melissa K., Dunn, Jeff, Smith, David P., Hughes, Suzanne, Yuill, Susan, Egger, Sam, O'Connell, Dianne L., Stein, Kevin, Frydenberg, Mark, Wittert, Gary

Phase of care prevalence for prostate cancer in New South Wales, Australia: a population-based modelling study

- Yu, Xue Qin, Luo, Qingwei, Smith, David P., Clements, Mark S., Patel, Manish I., O'Connell, Dianne L.

Prevalence and associations of general practitioners' ordering of "non-symptomatic" prostate-specific antigen tests: a cross-sectional analysis

- Magin, Parker, Tapley, Amanda, Kerr, Rohan, van Driel, Mieke, Davey, Andrew, Morgan, Simon, Henderson, Kim, Holliday, Elizabeth, Ball, Jean, Catzikiris, Nigel, Mulquiney, Katie, Spike, Neil

Prostate-specific membrane antigen positron emission tomography-computed tomography for prostate cancer: distribution of disease and implications for radiation therapy planning

- Gupta, Sandeep K., Watson, Tahne, Denham, Jim, Shakespeare, Thomas P., Rutherford, Natalie, McLeod, Nicholas, Picton, Kevin, Ainsworth, Paul, Bonaventura, Tony, Martin, Jarad M.

Proteins Annexin A2 and PSA in prostate cancer biopsies do not predict biochemical failure

- Lamb, David S., Sondhauss, Sven, Dunne, Jonathan C., Woods, Lisa, Delahunt, Brett, Ferguson, Peter, Murray, Judith, Nacey, John N., Denham, James W., Jordan, T. William

Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement

- Legge, Kimberley, Greer, Peter B., O'Connor, Daryl J., Wilton, Lee, Richardson, Matthew, Hunter, Perry, Wilfert, Alex, Martin, Jarad, Rosenfeld, Anatoly, Cutajar, Dean